| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17,842 |
13,736 |
$450K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
5,374 |
1,807 |
$233K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,034 |
4,003 |
$232K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
7,363 |
5,554 |
$108K |
| 99222 |
Initial hospital care, per day, moderate complexity |
2,091 |
1,489 |
$102K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,081 |
942 |
$53K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,236 |
1,810 |
$47K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
867 |
769 |
$40K |
| 11721 |
|
3,546 |
2,823 |
$35K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
821 |
664 |
$24K |
| 99307 |
|
2,654 |
2,037 |
$21K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,741 |
1,121 |
$15K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
417 |
326 |
$14K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
349 |
324 |
$14K |
| 99215 |
Prolong outpt/office vis |
141 |
135 |
$14K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
307 |
255 |
$13K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
897 |
396 |
$9K |
| 90670 |
|
762 |
726 |
$8K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
93 |
79 |
$8K |
| 11056 |
|
493 |
355 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,366 |
1,046 |
$6K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
154 |
57 |
$6K |
| 81025 |
|
776 |
568 |
$4K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
104 |
85 |
$4K |
| 90680 |
|
382 |
366 |
$4K |
| 90648 |
|
410 |
391 |
$4K |
| 90723 |
|
402 |
383 |
$4K |
| 70450 |
Computed tomography, head or brain; without contrast material |
153 |
104 |
$4K |
| 99220 |
|
87 |
59 |
$3K |
| 90688 |
|
236 |
211 |
$3K |
| 99219 |
|
70 |
51 |
$3K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
39 |
27 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
151 |
119 |
$2K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
268 |
53 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
417 |
291 |
$2K |
| 90633 |
|
170 |
159 |
$2K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
15 |
15 |
$2K |
| 99460 |
|
19 |
13 |
$1K |
| 99223 |
Prolong inpt eval add15 m |
24 |
16 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
182 |
135 |
$981.10 |
| 99381 |
|
13 |
12 |
$671.11 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
531 |
413 |
$609.67 |
| 99217 |
|
22 |
16 |
$458.59 |
| 90707 |
|
51 |
46 |
$430.20 |
| 90716 |
|
50 |
45 |
$420.64 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
43 |
29 |
$405.53 |
| 90647 |
|
28 |
25 |
$386.25 |
| 82962 |
|
91 |
79 |
$378.00 |
| 99218 |
|
14 |
14 |
$359.45 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
20 |
12 |
$305.70 |
| 87280 |
|
259 |
174 |
$296.01 |
| 90685 |
|
16 |
16 |
$247.20 |
| 73030 |
|
19 |
14 |
$213.60 |
| 81005 |
|
130 |
102 |
$212.45 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
77 |
41 |
$128.57 |
| 90734 |
|
12 |
12 |
$114.72 |
| 90649 |
|
15 |
15 |
$114.72 |
| 73630 |
|
20 |
14 |
$109.22 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
66 |
55 |
$96.00 |
| 74018 |
|
14 |
12 |
$66.54 |
| 73130 |
|
14 |
12 |
$45.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
15 |
12 |
$22.33 |
| Q2038 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) |
92 |
92 |
$21.66 |
| 87400 |
|
229 |
210 |
$19.61 |
| 3008F |
|
409 |
369 |
$0.00 |
| 3074F |
|
212 |
201 |
$0.00 |
| 0001A |
|
18 |
18 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
129 |
129 |
$0.00 |
| 1034F |
|
59 |
55 |
$0.00 |
| 1000F |
|
254 |
236 |
$0.00 |
| 99224 |
|
74 |
63 |
$0.00 |
| 3352F |
|
38 |
38 |
$0.00 |
| 1111F |
|
17 |
17 |
$0.00 |
| 1125F |
|
15 |
14 |
$0.00 |
| 1036F |
|
125 |
113 |
$0.00 |
| 1159F |
|
480 |
448 |
$0.00 |
| 3288F |
|
239 |
222 |
$0.00 |
| 1160F |
|
477 |
446 |
$0.00 |
| 3078F |
|
173 |
165 |
$0.00 |
| 3725F |
|
52 |
50 |
$0.00 |
| 0002A |
|
20 |
20 |
$0.00 |
| 1090F |
|
21 |
21 |
$0.00 |